Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 27 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Identification and Validation of a Lenvatinib Resistance-Related Prognostic Signature in HCC, in Which PFKFB4 Contributes to Tumor Progression and Lenvatinib Resistance
Jinfeng Wang, Jianfei Shi,Lili Mi,Ning Li, Xin Han,Man Zhao, Xiaoling Duan, Guangjie Han, Jiaojiao Hou,Fei Yin
BMC Gastroenterologyno. 1 (2025): 1-21
Cited0Views0WOSBibtex
0
0
Comparative Efficacy of Interventional Therapy with or Without Targeted Immunotherapy in Child-Pugh B Hepatocellular Carcinoma Patients: a Single-Center, Retrospective Study
Xu-Wei Guo,Man Zhao, Xiao-Ling Duan, Guang-Jie Han, Jin-Feng Wang, Jian-Fei Shi, Xin Han,Fei Yin,Guang Yang
Frontiers in oncology (2025): 1541805-1541805
Cited0Views0WOSBibtex
0
0
CD161, a Promising Prognostic Biomarker in Hepatocellular Carcinoma, Correlates with Immune Infiltration
Jinfeng Wang, Xiaoxiao Wang, Jianfei Shi,Yongjun Wang,Lili Mi,Man Zhao, Guangjie Han,Fei Yin
PeerJ (2025): e19055-e19055
Cited0Views0WOSBibtex
0
0
A Comparative Study on the Progression of Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
Xiaoling Duan,Man Zhao, Xiaolei Yin,Lili Mi, Jianfei Shi,Ning Li, Xin Han, Guangjie Han, Jinfeng Wang, Jiaojiao Hou,Fei Yin
ONCOLOGY (2025)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 27

#Citation: 156

H-Index: 8

G-Index: 12

Sociability: 4

Diversity: 2

Activity: 9

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn